Pediatric Neuroblastoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

By Treatment Type (Chemotherapy, Immunotherapy, Radiation Therapy, and Others), and by End-User (Hospitals, Specialty Clinics and Others), by region, and Competition

Published	Pages	Publisher	Report code
Nov 2023	190	TechSci Research	ASDR-640740

Published: Nov 2023 - Pages : 190 - Publisher : TechSci Research - Report code : ASDR-640740

1. United Therapeutics Corporation
2. APEIRON Biologics AG
3. Baxter International Inc.
4. Cell Ectar Biosciences Inc.
5. Pfizer Inc.
6. Bayer AG
7. Provectus Biopharmaceuticals Inc.
8. Sartorius AG
9. Amgen Inc.
10. F. Hoffmann-La Roche AG

Global Pediatric Neuroblastoma Treatment Market Size study, by Treatment Type (Chemotherapy, Immunotherapy, and Others), by Distribution Channel (Hospital Pharmacies and Retail Pharmacies) and Regional Forecasts 2022-2028

This report can be of interest as well:

Global Pediatric Neuroblastoma Treatment Market Size study, by Treatment Type (Chemotherapy, Immunotherapy, and Others),...

Published: May, 2022 | Report code: ASDR-601468

Mark your calendar:

Veterans Affairs Healthcare Summit

23 July - 24 July, 2024
Arlington, United States